Top Suppliers:I want be here


922150-11-6

922150-11-6 structure
922150-11-6 structure
  • Name: SCH 529074
  • Chemical Name: N1-(2-((4-(bis(4-chlorophenyl)methyl)piperazin-1-yl)methyl)quinazolin-4-yl)-N3,N3-dimethylpropane-1,3-diamine
  • CAS Number: 922150-11-6
  • Molecular Formula: C31H36Cl2N6
  • Molecular Weight: 563.56400
  • Catalog: Signaling Pathways Apoptosis MDM-2/p53
  • Create Date: 2016-05-10 00:17:03
  • Modify Date: 2024-01-11 16:43:19
  • SCH529074 is a potent and orally active p53 activator. SCH529074 binds specifically and conformation-dependently to p53 DBD ( DNA binding domain) with a Ki of 1-2 μM in a saturable manner. SCH529074 restores mutant p53 function and interrupts HDM2-mediated ubiquitination of wild Type p53. SCH529074 can be used for the study of non-small-cell lung carcinoma (NSCLC)[1][2].

Name N1-(2-((4-(bis(4-chlorophenyl)methyl)piperazin-1-yl)methyl)quinazolin-4-yl)-N3,N3-dimethylpropane-1,3-diamine
Synonyms sch 529074
Description SCH529074 is a potent and orally active p53 activator. SCH529074 binds specifically and conformation-dependently to p53 DBD ( DNA binding domain) with a Ki of 1-2 μM in a saturable manner. SCH529074 restores mutant p53 function and interrupts HDM2-mediated ubiquitination of wild Type p53. SCH529074 can be used for the study of non-small-cell lung carcinoma (NSCLC)[1][2].
Related Catalog
Target

Ki: 1-2 μM (p53 DBD)[2]

In Vitro SCH529074 (2-4 µM; 24 hours) causes significant reduction in cell viability, it causes a significant decreasing to 20-25% in p53 mutant cells (H157, H1975 and H322) and to 68% in the p53 WT cell line A549 at 4 µM[1]. SCH 529074 (2 and 4 µM) induces NSCLC cells (H157, A549, HCT116 and HCT116 p53-/-) arrested at the G0/G1 phase (59%; 72%; 66%; and 57%) compared with the control cells following low concentration (2 µM) of treatment[1]. SCH 529074 (2-4 µM; 24 hours) induces the early and late apoptotic rates at 2 µM in H1975 cells. In H157 cells, SCH 529074 treatment induces early and late apoptosis. Similarly, in A549 cells, 2 and 4 µM of SCH 529074 significantly increased early and late apoptosis. In line with that, in colon cancer cells, in HCT116 cells, 4 µM of SCH 529074 causes a significant induction of early and late apoptosis, and 4 µM of SCH 529074 significantly induces early apoptosis in HCT116 p53-/- cells[1]. SCH 529074 (2-6 µM; 24 hours) increases the protein levels of PUMA and p21 revealed to 4 or 6 µM in the cancer cell lines regardless of their p53 status[1]. Cell Viability Assay[1] Cell Line: p53 mutant cells (H157, H1975 and H322) and p53 WT cell line A549 Concentration: 2 µM; 4 µM Incubation Time: 24 hours Result: Inhibited cancer WT and mutant cell viability. Cell Cycle Analysis[1] Cell Line: H1975, H157, A549, HCT116, HCT116 p53-/- cells Concentration: 2 µM, 4 µM, 6 µM Incubation Time: 24 hours Result: Induced apoptosis in all assessed NSCLC cell lines irrespective of their p53 mutational status. Western Blot Analysis[1] Cell Line: H1975, H322, H157, A549, HCT116, HCT116 p53-/- Concentration: 2 µM, 4 µM, 6 µM Incubation Time: 24 hours Result: Increased PUMA and p21 protein expression.
In Vivo SCH529074 (oral administration; 30 or 50 mg/kg; twice daily; 4 weeks; started on day 3 until day 31) causes 79 and 43% reduction of tumor growth at 50 and 30 mg/kg doses, respectively. the degree of tumor inhibition correlates with the plasma exposure of the compound (0.26–0.55 μm at 30 mg/kg and 0.39-0.79 μm at 50 mg/kg, 2-12 h post final dosing) in human DLD-1 colorectal cancer xenograft[2]. Animal Model: Female nude mice, 5–7 weeks of age, received subcutaneous inoculation of DLD-1 human colorectal carcinoma cells[2] Dosage: 30 or 50 mg/kg Administration: Oral administration; twice daily; 4 weeks; started on day 3 until day 31 Result: Inhibited tumor growth
References

[1]. Miljana Nenkov, et al. Growth Inhibitory Role of the p53 Activator SCH 529074 in non‑small Cell Lung Cancer Cells Expressing Mutant p53. Oncol Rep. 2020 Jun;43(6):2073-2082.

[2]. Mark Demma, et al. SCH529074, a Small Molecule Activator of Mutant p53, Which Binds p53 DNA Binding Domain (DBD), Restores Growth-Suppressive Function to Mutant p53 and Interrupts HDM2-mediated Ubiquitination of Wild Type p53. J Biol Chem. 2010 Apr 2;285(14):10198-212.

Molecular Formula C31H36Cl2N6
Molecular Weight 563.56400
Exact Mass 562.23800
PSA 47.53000
LogP 6.15620